APA (7th ed.) Citation

Luft, T., Gras, L., Koster, L., Kröger, N., Schröder, T., Platzbecker, U., . . . Robin, M. (2025). Methotrexate versus mycophenolate mofetil prophylaxis in allogeneic hematopoietic cell transplantation for chronic myeloid malignancies: A retrospective analysis on behalf of the chronic malignancies working party of the EBMT. American journal of hematology, 100(1), . https://doi.org/10.1002/ajh.27531

Chicago Style (17th ed.) Citation

Luft, Thomas, et al. "Methotrexate Versus Mycophenolate Mofetil Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Malignancies: A Retrospective Analysis on Behalf of the Chronic Malignancies Working Party of the EBMT." American Journal of Hematology 100, no. 1 (2025). https://doi.org/10.1002/ajh.27531.

MLA (9th ed.) Citation

Luft, Thomas, et al. "Methotrexate Versus Mycophenolate Mofetil Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Malignancies: A Retrospective Analysis on Behalf of the Chronic Malignancies Working Party of the EBMT." American Journal of Hematology, vol. 100, no. 1, 2025, https://doi.org/10.1002/ajh.27531.